ãµã£ãããã€èãç®æããªãã³ã¬â¡ ããªãžã¥ã©ã³ ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã«ã ãªãžã¥ã©ã³ãªãã§ã¯ã®ãµãŒã¢ã³ã®æŽ»æ§DNAããæœåºããç¬èªã®c-PDRN*¹ãšã»ã©ããNP*²ãé åâš ãã£ãšããšããŠæã®ããªãã€æãè¯ãâ¡ ä¹Ÿç¥æããŠããšãã¯é ŒããŸããð
ãã£ãšèŠãããããã¢ã€ãã REJURANÃçŸå®¹æ¶²
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬103äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
REJURAN ã¿ãŒã³ãªãŒããŒã¢ã³ãã« | 2,728å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬180äœ | èã®è¡šé¢ãã€ãããšããŠããŠå€æ¹ã®ããã¿ãæ°ã«ãªãã«ãããªããŸããïŒ | 詳现ãèŠã | |
REJURAN ã¢ã€ã¹ãã£ãŒããªãŒãã¡ã³ãã¢ã³ãã« | 3,850å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬195äœ | ãã£ã¡ããšããã¯ãªã¢ãªãã¯ã¹ãã£ã èãªãã¿ãããã£ãïŒïŒïŒïŒãã£ã±ãããšæããããã£ããä¿æ¹¿ | 詳现ãèŠã |
çŸå®¹æ¶²ã©ã³ãã³ã°
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
SHISEIDO ã¢ã«ãã£ãã¥ãŒã³â¢ ãã¯ã©ã€ãžã³ã° ã»ã©ã | 9,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬20äœ | ã¹ã«ã¹ã«ã£ãšäŒžã³ãŠãèã«ãªãããšã»ãã®ããã€æãæããŸãã åŸèã¯ãããã | 詳现ãèŠã | |
DECORTà ãªããœãŒã ã¢ããã³ã¹ãããªãã¢ã»ã©ã | 12,650å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬15äœ | ããããªã£ãããŸã£ãèãæãããã»ãããŠããããããªã€ã¡ãŒãžã§ããïŒ | 詳现ãèŠã | |
ã© ããã·ã¥ ã㌠ãšãã¡ã¯ã© ããŒã«ã±ã¢ ã»ã©ã | 5,280å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬51äœ | ããããšãã¿ã®ãããã¯ã¹ãã£ãŒã§ã䌞ã³è銎æã¿å ±ã«âã¹ãšã€ããªããã©ãã£ãšãä¿æ¹¿ããŠãããŸãïŒ | 詳现ãèŠã | |
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬103äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
Torriden ãã€ãã€ã³ ã»ã©ã | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬85äœ | èã«ã®ãããšããã«ã¹ããšéŠŽæã¿ãŸãã銎æããšãã¿ã€ãããããµã©ãµã©ã«ãªãïŒ | 詳现ãèŠã | |
Anua ã¢ãŒã©ã€ã³é ž15 ã€ã³ãã³ã¹ã«ãŒãã³ã°ã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬105äœ | 軜ãããªãã¯ã¹ãã£ãŒã§çŽ æ©ãèã«éŠŽæã¿ã最ããããªäœ¿ãå¿å°ã§ãâš | 詳现ãèŠã | ||
numbuzin 5çª çœçã°ã«ã¿ããªã³ïŒ£çŸå®¹æ¶² | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬19äœ | ãšãã¿ã®ãããã¯ã¹ãã£ãŒãªã®ã«ããããããªãðð» | 詳现ãèŠã | |
ã¢ãŒã¬ã¹ ããŒã¹ã ãã³ã㌠X | 7,150å(ç·šééšèª¿ã¹/ãªãŒãã³äŸ¡æ Œ) |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬44äœ | ãã¿ãã¿ãã«ããã èãªãã¿ãããã®ã§äœ¿ããããïŒãèã«ãã€ãã§ãã®ãå¬ããð | 詳现ãèŠã | |
GUERLAIN ã¢ãã€ãŠ ãã€ã€ã« ãŠã©ãŒã¿ãªãŒ ãªã€ã« ã»ãã | 19,800å |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬91äœ | 詳现ãèŠã | ||
manyo ã¬ã©ã¯ãã€ã¢ã·ã³2.0ãšãã»ã³ã¹ | 3,190å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬14äœ | çŸå®¹æ¶²ã ãã©ãµã©ãµã©ããŠããŠããèã«éŠŽæãïŒ åŸã®ã¹ãã³ã±ã¢ã«é¿ããªããããã¿ã€ããªããŠè¯ã⪠| 詳现ãèŠã |
ãã¿ðãã©ããããã®äººæ°ã¯ãã³ã
æã«å¡ã£ãŠã¿ããšçŽ«è²ãæ¿ãå°è±¡ã§ããâšãšã£ãŠã綺éºð é»ã®ããŒã¹ã«éã»çŽ«ã®ããŒã«ãé åãããã®ãè²ã«ãªã£ãŠãããðž ããããªãç³ã«éææãåºããŠãããã®ãå¬ããã£ãã§ãð¥ºð
ãã£ãšèŠã97
2
- 2024.04.09
æ·¡ã玫è²ã®ãªããããªãã¯ã¹ãã£ãŒã§ å¡ãåºãããã䜿ããããã£ãã§ãïŒ ãã®ã«ã©ãŒãšãã¯ã¹ãã£ãŒãæ¯ç©Žã«å ¥ã蟌㿠æ¯ç©Žå¯Ÿçã«ãðââïžâ 䜿çšåŸã¯ãã¡ã£ãšæœ€ããããèã«ãªããŸãâšïž éŠããã»ãŒãªãã®ãè¯ãã£ãã§ãâºïž
ãã£ãšèŠã94
3
- 2024.05.05
ããã£ãšãããã¯ã¹ãã£ãŒã§ãŠã©ãŒã¿ãŒãã«ãŒãã®ãã¹ã«ã©ãŸã§ãèœãšãã¡ããã¯ã¬ã³ãžã³ã°ãªã€ã«âšïž èªç¶ç±æ¥ã®æ€ç©æ§ãªã€ã«99%é åãããŠããã®ã§äœåºæ¿ð ã¡ã€ã¯ãèœãšãã ãã§ãªãæ¯ç©Žæ±ããPM2.5ã®é€å»(å šãŠã§ã¯ãããŸãã)ãŸã§ã±ã¢ããŠãããã®åããªãïŒð³ ã°ãªãŒã³ãã£ãŒãã¯ã¬ã³ãžã³ã°ãªã€ã«ã¯éã£ãããæåðâšïžãã¡ããã¡ãããããããŠãŸãð«¶ð» ãã³ãåŒãªã®ã§äœ¿ããããã®è¯ãã£ãã§ãðââïž
ãã£ãšèŠã94
2
- 2024.03.13
ãšããŽã©ã¹ããã©ã«ãã«ãããŠããŒã¢ãŒãããŒãžã¥äœ¿ã£ãŠã¿ãŸããðã¢ã€ã·ã£ããŠã»ããŒã¯ã»åã«äœ¿ããäžèœããŠããŒâšïžãµã©ããšããç²è³ªã§ãµãããè²ã¥ããŠãããã®ãè¯ãã£ãã§ãðãè²ã¯ã€ãšãç§ã®æ¹ã«ãŽã£ããã§ãïŒ#ETVOS#ã¢ã€ã·ã£ããŠ#ããŒã¯#ãªã...
ãã£ãšèŠã94
3
- 2023.11.04
ã¯ã·ã¯ã»ä¹Ÿç¥ããã¿ãæ°ã«ãªãæ¹ã«ãæ¿å¯ãªã¯ãªãŒã ãé·æéä¿æ¹¿ãèèããé²ãã§ãããŸãâ ãã€ã¢ã·ã³ã¢ããïŒã°ãªãã«ãªãã³é ž2Kã«ä¿æœ€ã¢ããé žãé åããå¬ããæåã°ããðâ¡ ããŒã ã®æ§ãªãã¯ã¹ãã£ãŒã§èã«ã®ãããšãã£ãšéŠŽæã¿ããã£ãšãä¿æ¹¿ãããã®ãæããŸããâºïž å€ã®ã±ã¢ã«æ²¢å±±äœ¿ããããªãšæããŸãðââ¬ð ã©ã¡ããç¡éŠæã§èã«åªããåŠæ¹ðž
ãã£ãšèŠã92
2
- 2024.02.05
äœåºæ¿åŠæ¹ã§å¬ããð¿ ãŠã©ãŒã¿ãŒã®å±€ã¯ãã¢ã«ãã³é žãé åãããŠããããªã±ãŒããªç®ãå£ãåªããèœãšããŠãããŸãâºïžð«¶ð» ãŠã©ãŒã¿ãŒãã«ãŒããã¹ã«ã©ããã£ã³ããªãããã¢ã€ã·ã£ããŠã¯ããããšèœã¡ãŸããâšïž 䜿çšåŸãèã®ã€ã£ã±ããæããªãã£ãã®ãè¯ãã£ãã§ãð
ãã£ãšèŠã92
2
- 2024.03.15
åå詳现æ å ±REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã«
- ãã©ã³ãå
- REJURAN(ãªãžã¥ã©ã³)
- ã©ã³ãã³ã°IN
- å šäœã©ã³ãã³ã°å¹Žä»£å¥ã©ã³ãã³ã°è質å¥ã©ã³ãã³ã°
- 容éã»åèäŸ¡æ Œ
- 30ml: 8,250å
- åå説æ
- ãªãžã¥ã©ã³ã®ãªãªãžãã«PDRNãå ¥ã£ãŠããããªãã€çŸå®¹æ¶²ã c-PDRNâ»1 ããã€ã¢ã·ã³ã¢ããâ»2ããã¢ã«ãã³é žïŒ®ïœâ»2 ãã«ã³ãŸãŠæ ¹ãšãã¹â»3ãé åã è§è³ªå±€ãŸã§æœ€ããäžããèãªãºã ãæŽããâ»4ããšã§åŒŸåã®ããèæ¬æ¥ã®çŸãããžã ãªãžã¥ã©ã³æé«æè¡ã¹ããŒãšã€ãžã³ã°â»5äžèœçŸå®¹æ¶²ã â»1ãå æ°Žå解 : æŽèæå â»2ãé åç®çïŒä¿æ¹¿ â»3ãé åç®ç: æŽèæå â»4ãèããããã£ãŠããããããªç¶æ ã®ããš â»5ã幎霢ã«åãããã±ã¢ã®ããš
- ã¡ãŒã«ãŒå
- Pharma Research
- ã«ããŽãª
- ã¹ãã³ã±ã¢ã»åºç€åç²§å > çŸå®¹æ¶²
ãã©ããŒãããŠããã ããŸããâš ãããããé¡ãããŸãð